Kester Kent Edward Insider Trading -- Recent SEC Form 4 Transactions

Kester Kent Edward (CIK 2087469) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-10-10). Recent activity: Buy TTRX (10,000 shares). Source: SEC Form 4.

DateCompanyRoleTypeSharesValue
2025-10-10Turn Therapeutics Inc. (TTRX)DirectorBuy10,000$0

Source: SEC Form 4 filings · as of 2025-10-10